Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.
Introduced First Reading Assembly Referred to AHE
Email me when A 4957 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 4957. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill lets licensed health‑care providers in New Jersey prescribe Schedule II controlled substances through real‑time video visits, even if they have never examined the patient in person. It sets standards for provider licensing, patient consent, record‑keeping, and follow‑up care, while also clarifying rules for mental‑health screenings and minors. The change removes the current requirement for an initial and quarterly in‑person exam, aiming to expand telehealth access.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 4957
3 free questions a day, no accountHistory
- Introduced, Referred to Assembly Health Committee
Sponsors
- Tully, Chris · sponsor
- Kearney, Vincent M.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 4957 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 4957 freeOr ask your AI assistant about A 4957 directly:
Add to Claude, ChatGPT or Cursor